AstraZeneca agrees to pay $560K to resolve alleged race, gender-based pay discrimination at Wilmington, Delaware facility
MoreToday, the European Commission signed a third contract with the pharmaceutical companies BioNTech and Pfizer.
MoreAnnouncing that the United States is taking additional steps to help the world combat the coronavirus pandemic, President Joe Biden on Monday said the country will be sending 20 million more doses of its COVID-19 vaccines abroad by the end of June.
MoreWHO Director-General Dr Tedros Adhanom Ghebreyesus welcomed the Government of Sweden’s announcement today to share 1 million doses of the AstraZeneca vaccine with the COVAX Facility to provide life-saving vaccines to people at risk from COVID-19 in low income countries.
MoreMore than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines.
MoreThe COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago.
MoreAs of 17 March 2021, more than 120 million cases of COVID-19 infections, with more than 2 million deaths, had been reported globally. Vaccination remains a critical tool to help prevent further illness and death and to control the pandemic.
MoreSome countries in the European Union have temporarily suspended use of the AstraZeneca COVID-19 vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine.
MoreThe UN World Health Organization (WHO) said on Friday that it was aware of blood clot concerns linked to “a specific batch” of AstraZeneca/Oxford COVID-19 vaccine, but maintained that to date, no-one has died from any coronavirus vaccine.
MoreThe World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More